Patients with colorectal cancer who walked more had less fatigue and better quality of life, regardless of how active they were at diagnosis.
|Articles|March 27, 2023
Taking a Positive Approach to Relapse
Advertisement
In this blog, IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie talks about taking a positive approach when myeloma patients are faced with a relapse. He discusses challenges in figuring out if a relapse is occurring or not. He also advises a recheck for a biochemical relapse. Dr. Durie also highlights opportunities of when to start treatment.
Advertisement
Related to this article
CURE spoke with Oncology Aesthetics & Wellness founder, Deborah A. McDowell, about hair preservation before, during and after cancer treatment.
A genomic test led physicians to change extended endocrine therapy recommendations for 42% of people with early-stage HR-positive breast cancer.
A wife reflects on her husband’s cancer treatment, finding comfort, hope and connection in their simple ritual of sharing bagels before each treatment.
Survivors and experts share what to do before your first chemo infusion, from scalp cooling and saving your hair to skin care and building a support team.
After two relapses of acute lymphoblastic leukemia, Hannah Koepsell received CAR-T cell therapy. A pediatric oncologist explains why leukemia can return after treatment and how researchers are working to make CAR-T responses last longer.
FDA approves Welireg plus Lenvima for advanced clear cell kidney cancer after PD-1 or PD-L1 treatment, offering a new treatment option.
These seven breast cancer clinical trials are recruiting patients now, spanning early-stage, HR-positive, HER2-positive and triple-negative disease.
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Welireg Plus Lenvima for Advanced Kidney Cancer After Immunotherapy
2
7 Breast Cancer Clinical Trials Currently Enrolling in the US
3
What to Do Before Your Chemo Infusion: A Checklist From People Who've Been There
4
How Paxalisib Targets Treatment Resistance in Breast Cancer
5